| Aspen Pharmacare is in better shape after restructuring its business and disposing of assets that were no longer core. That's helped it reduce debt - and its interest bill - resulting in a stronger first-half performance as it prepares to start manufacturing the Janssen Covid-19 vaccine at its Gqeberha (Port Elizabeth) facility. Brait must wish that members of its Virgin Active gym chain in the UK could also get back in shape. Instead, its health clubs there remain closed, as they have been for most of past year. Along with other stakeholders and creditors, it has come up with a new restructuring plan to keep the chain afloat until restrictions ease. Famous Brands says the impact of Covid-19 on its operations here and in the UK has also been severe, resulting in a big decline in full-year sales. Don't miss the latest results from Standard Bank and Sanlam in Share360 as we turn the spotlight on the financial services sector. And we wrap up the week with the latest mergers and acquisition news from our partners at DealMakers. Have a good weekend. Stephen Gunnion Managing Editor, InceConnect
The latest from Ingham Analytics If you're in for a horror story then we've got one up on Netflix - a note entitled "Is there a TARGET(2) on my back?" This examines so-called Target2 imbalances in the Eurozone and follows on from the recent central banking note "Now what do they want?" Andrew Kinsey examines the uncomfortable truth of what is at the heart of a fundamentally unstable euro. Could the euro crack? What are the implications? On Sasol, the story also isn't pleasant, as a "A fifteen-year gulf" assesses. | 